海外の下垂体腫瘍摘出術のベスト医師 — ページ2

アクピナル医師は下垂体腫瘍手術を専門としており、Valued Med Hub病院で専門的なケアを提供しています。

• 脳神経外科における長年の経験
• 低侵襲技術に重点を置く
• 包括的なケアのために多職種チームと連携

グナルディ医師は、Valued Med Hub病院にて内視鏡下頭蓋底手術および下垂体腫瘍手術を専門としています。

• 2001年より認定脳神経外科医
• 脳神経外科准教授
• 神経腫瘍学的手術の専門家
• 医療活動の傍ら、10冊の児童書を執筆

Seehirunwong医師は画像診断を専門とし、イントララット病院にて治療方針を決定するための画像診断検査の読影を行っています。

• プリンス・オブ・ソンクラー大学医学部卒業
• 画像診断専門医認定
• 画像ガイド下治療手技の専門家
• 医療提供者と密接に連携し、正確な診断を保証

Tural Rajabov医師は脳神経外科医です。脳腫瘍、脊髄腫瘍、中枢神経系外傷、水頭症の治療を行っています。また、内視鏡下頭蓋底手術、脊椎手術、末梢神経手術も専門としています。

経歴：トビリシ国立医科大学医学部（2010–2016年）。トビリシのInnova Medical Centreにて脳神経外科インターンシップ（2016–2018年）。アゼルバイジャン医科大学にて脳神経外科レジデンシー（2019–2024年）。

所属学会：北米頭蓋底学会（NASBS）、欧州脳神経外科学会（EANS）、アゼルバイジャン脳神経外科医協会（ANEA）。アゼルバイジャンのバクーにあるBaku Medical Plaza Hospitalに所属しています。

マルガリット・ナヴォ教授は、低侵襲技術を用いて100件以上の頭蓋底腫瘍手術と70件の髄膜腫摘出術を行ってきました。

• スラスキー医療センターの脳神経外科部長
• 鼻腔からの内視鏡的摘出術を専門とし、回復が早い
• 米国で高度な頭蓋底外科の訓練を受ける
• イスラエル脳神経外科学会会員

ヴィオラ・フォックス博士は、認定された学際的がんセンターであるBKZゾーリンゲンの血液学・腫瘍学・緩和ケアクリニックを率いています。

• 化学療法、免疫療法、標的療法を専門とする
• 分子診断の専門知識を持つ遺伝学の有資格専門医
• 革新的ながん治療のための分子生物学研究に積極的に取り組んでいる
• ドイツおよびアメリカの腫瘍学会の会員

複雑な脳腫瘍の摘出を専門とするクリステスク医師は、ポンデラス大学病院にて高度な外科手術技術と心のこもったケアを融合させています。

• フランスのトップ病院でレジデントを修了
• 低侵襲脳神経外科の専門家
• 正確さと患者中心のアプローチで知られる

ウヤル医師は、Medical Park Antalya Hospital Complexにて下垂体腫瘍手術を含む複雑な脳神経外科症例を専門としています。

• SSK Göztepe研修病院にて脳神経外科レジデンシーを修了
• 脳神経外科において_doctor_9315_年以上の経験
• 脳脊髄液腫瘍および動脈瘤の手術に精通
• イスタンブール医師会会員

セルダル・グンゴール教授は小児神経学を専門とし、豊富な学術的および臨床的経験を有しています。

• ハジェテペ大学での小児神経学の専門研修
• 小児神経学における_doctor_9534_年以上の経験
• イノニュ大学医学部教授
• 小児神経学に関する研究論文の発表

シナール教授は、Medical Park Bahcelievler病院における下垂体腫瘍の症例に対し、38 年の心臓血管外科の専門知識を提供します。

• カナダ有数の機関であるオタワ大学心臓センターで研修
• アルトゥンバシュ大学心臓血管外科教授
• 欧州心臓血管外科学会会員

エルカン・カプタノグル教授は、頭蓋および脊椎の神経外科において豊富な経験を持ち、複雑な下垂体腫瘍の手術を専門としています。

• _doctor_7656_年以上の神経外科経験
• 下垂体腺腫に対する低侵襲手術の専門家
• 65本の国際的な科学論文を発表
• マルマラ大学神経外科の元部長
• EUROSPINEおよびトルコ神経外科学会の会員

下垂体内視鏡手術の専門医。ハリル・ジャン医師は、İstinye University Liv Hospital Topkapıにて低侵襲手術を行っています。

• 内視鏡技術の高度な訓練を受けた脳神経外科教授
• 脊椎および脳神経外科の解剖学に関する多数の研究を発表
• 下垂体腫瘍および複雑な頭蓋底手術の専門家

Ali Ihsan Anadolulu教授は、セントラル病院にて下垂体腫瘍手術を専門としており、小児症例に注力しています。

• 消化器疾患の専門知識を持つ経験豊富な医師
• イスタンブール大学ジェラフパシャ医学部にて専門研修を修了
• 科学論文や教科書を通じて医学教育に貢献
• 低侵襲小児外科に関心を持つ

ハサン・ムトル医師は、医療腫瘍学の訓練を受けた准教授であり、メディカル・パーク・アンタルヤにて下垂体腫瘍の症例に対する専門的な専門知識を提供しています。

• 内科の認定医であり、医療腫瘍学のサブスペシャリティを持つ
• 米国にて高度な腫瘍学技術の訓練を受ける
• 腫瘍に対する標的療法および免疫療法の専門家
• がん治療における次世代遺伝子研究を実施
• 現在、メディカル・パーク・アンタルヤ病院複合施設にて勤務

アレムダル医師は、Medical Park Antalya Hospital Complexにて下垂体腫瘍手術を専門としており、トルコのトップクラスの医療機関で培った豊富な経験を有しています。

• 下垂体腫瘍に焦点を当てた腫瘍内科の認定医
• トルコ有数の医学部であるアクデニズ大学で研修
• 複雑な内分泌疾患の症例において_doctor_9570_年以上の経験
• JCI認証を受けた病院で、高度な脳神経外科設備を備えて勤務

_doctor_2825_年_の脳神経外科経験 – キー医師はハダッサ大学病院にて下垂体腫瘍手術を専門としています。

• オックスフォード大学およびクリーブランド・クリニックで研修
• ロイヤル・メルボルン病院脳神経外科元部長
• 米国脳神経外科医協会よりロナルド・ビットナー賞を受賞
• 世界中の数多くの権威ある脳神経外科関連学会の会員

サミュエル・モスコヴィッチ医師は、_doctor_2823_年にわたり脳神経外科分野で67本の査読付き論文を共同執筆しており、複雑な脳疾患における深い専門知識を有しています。

• 類表皮嚢胞、神経鞘腫、神経サルコイドーシスを専門とする
• 6つの脳神経外科疾患において高く評価されている
• エルサレムのハダッサ医療センターで診療を行っている
• 高度な血管内塞栓術およびステント留置術を実施している

アントン・ウォール博士は、シェバ医療センターの脳腫瘍ユニットのディレクターです。神経腫瘍学および複雑な脳腫瘍手術を専門としています。米国のメイヨークリニックでフェローシップを修了しました。ウォール博士は、2026年にニューズウィーク誌によって世界第7位にランクされた病院に勤務しています。神経機能を温存しながら腫瘍を切除することに重点を置いています。

• 覚醒下開頭術および蛍光ガイド下手術を行い、脳機能を保護します。
• 複雑な処置中に術中MRIおよび機能的脳マッピングを使用します。
• 膠芽腫および革新的な治療法に関する多数の査読済み研究の著者です。
• イスラエルの専門医認定および有効な医師免許を保持しています。

ヤーコフ・ローレンス医師は、シェバ医療センターの放射線腫瘍科部長です。精密放射線治療と神経腫瘍学を専門としています。ローレンス医師は、膵臓がんの疼痛管理のための腹腔神経叢ラジオサージェリー（放射線外科）の先駆者です。専門分野における最高の名誉の一つであるFASTROの称号を保持しています。

• シェバ医療センターの消化器がんプログラムを主導。
• 脳腫瘍および神経系がんに対する定位放射線外科手術を実施。
• 個別化された放射線プロトコルに関する280以上の科学論文を執筆。
• トーマス・ジェファーソン大学で放射線腫瘍学のフェローシップ研修を修了。

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.